SLC1A2 and Alzheimer disease: These two oligodendrocyte factors are accompanied by lower expression of Astrocyte factor 6 (with expression of SLC1A2) in cortical tissue in individuals with a clinical diagnosis of Alzheimer’s dementia (Fig. 2D,E), thus providing additional candidate gene expression programs that are potentially depleted in cognitively impaired individuals.